Treatment Trial of Subclinical Hypothyroidism in Down Syndrome
Status:
Completed
Trial end date:
2017-10-18
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to learn about the effects of treating subclinical
hypothyroidism (SCH) with thyroid hormone replacement in children and adolescents with Down
syndrome (DS). We hypothesize that treatment of SCH with thyroid hormone replacement will
improve cardiometabolic health and quality of life.
Phase:
N/A
Details
Lead Sponsor:
Children's Hospital of Philadelphia
Collaborator:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)